Showing results (101-110 of 220) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|July 14, 2022
Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trialJohn M Pagel, Jacob D Soumerai, Nishitha Reddy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphomaAjay K Gopal, Ted A Gooley, Joseph G Rajendran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenograftsKrishnan Subbiah, Don K Hamlin, John M Pagel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphomaAjay K Gopal, Joseph G Rajendran, Ted A Gooley, et al.
Cancer Research|January 2, 2009
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemiaJohn M Pagel, Dana C Matthews, Aimee Kenoyer, et al.
Cancer Research|September 28, 2014
In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia modelEthan R Balkin, Aimee Kenoyer, Johnnie J Orozco, et al.
Blood Advances|May 13, 2020
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndromeJe-Hwan Lee, Stefan Faderl, John M Pagel, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 19, 2020
COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO SupportMatthew E Hartman, Roland A Hernandez, Krish Patel, et al.
Cancer Research|February 27, 2009
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211Hirohisa Nakamae, D Scott Wilbur, Donald K Hamlin, et al.
Blood|November 29, 2007
Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapyJohn M Pagel, Nathan Hedin, Lacey Drouet, et al.
Pageof 22